Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-051219
Filing Date
2015-06-08
Accepted
2015-06-08 20:43:38
Documents
1
Period of Report
2015-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5052
  Complete submission text file 0001209191-15-051219.txt   6450
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address
Aryeh Jason (Reporting) CIK: 0001376960 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 15919647